Grin Therapeutics, Inc.
Clinical trials sponsored by Grin Therapeutics, Inc., explained in plain language.
-
Hope for rare brain disorder: new drug trial targets seizures and symptoms
Disease control Recruiting nowThis study tests an experimental drug called radiprodil in people with a rare genetic brain condition called GRIN-related neurodevelopmental disorder. The trial includes two groups: one with frequent seizures and one with other symptoms but fewer seizures. Participants will eithe…
Phase: PHASE3 • Sponsor: GRIN Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Liver function may change how this drug works – study seeks answers
Knowledge-focused Recruiting nowThis study looks at how the body processes a single dose of radiprodil in adults with mild, moderate, or severe liver problems compared to healthy adults. About 40 participants aged 18 to 75 will receive one 15 mg pill and be monitored for about 6 days. The goal is to see if live…
Phase: PHASE1 • Sponsor: GRIN Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC